In addition, an endogenous product, 4-hydroxynonenal, which is associated with several chronic diseases, has been shown to act as a potential activator of TRPA1, supporting the relevance of TRPA1-activation in chronic pain disorders such as migraine [65]. The gene discussed is TRPA1; the disease is migraine disorder.